CARRIE PORTERFIELD: Open Payments
NPI 1467078790 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,529 in 134 payments from 16 companies in 2025. Trend: 2023 $1,707 · 2024 $2,353 · 2025 $2,529
Food & beverage: $2,430Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $402 |
| ABBVIE INC. | 26 | $400 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $235 |
| Madrigal Pharmaceuticals | 9 | $225 |
| QOL Medical, LLC | 9 | $224 |
| GENZYME CORPORATION | 10 | $201 |
| Aimmune Therapeutics, Inc. | 10 | $186 |
| Celltrion USA Inc. | 9 | $137 |
| Phathom Pharmaceuticals, Inc. | 5 | $93 |
Products named: TREMFYA, DUPIXENT, XIFAXAN, ENTYVIO, REZDIFFRA, Sucraid, RINVOQ, VEGZELMA.
Industry payments across MS — which companies pay providers there.
